Targeting AXL-expressing, immunotherapy-resistant tumors with EnaV causes immune-stimulating tumor microenvironment. »
01/27/21

FACBC PET/CT demonstrated increased detection of recurrent prostate cancer. »
12/06/20

Effusion SMRP levels exclusively high in epithelioid MPM. »
08/02/19

GACAT3 may be novel target for diagnosis and treatment of bladder cancer. »
11/10/20

Positive PH-BCS group (n=44) had significantly better prognoses. »
12/22/20

Both loss of PSAT1 and removal of serine from diet necessary to suppress CRC xenograft growth. »
01/25/21

Both treatment methods had high acceptability. »
01/20/20

Significant difference in ppo%DLco observed for respiratory complications. »
02/09/21

Prior cancer had no significant association with worse outcomes. »
02/09/21

Metabolomic analysis demonstrated that ONC201 reversed obesity-driven upregulation of lipid biosynthesis. »
02/08/21